Children hospitalized for juvenile arthritis in the United States

Area of Science:

• Pediatric Rheumatology
• Autoimmune Diseases
• Health Services Research

Background:

• Juvenile arthritis (JA) is a significant autoimmune condition impacting pediatric populations.
• Understanding the epidemiology and healthcare burden of JA is crucial for public health initiatives.

Purpose of the Study:

• To evaluate the impact and characteristics of juvenile arthritis (JA) hospitalizations in the United States using national inpatient data.
• To identify demographic trends, healthcare costs, and length of stay associated with pediatric autoimmune conditions.

Main Methods:

• Utilized the 2017 National Inpatient Sample (NIS) database.
• Analyzed weighted admission data for patients aged 0-18 diagnosed with JA.
• Extracted demographic information, insurance coverage, total charges, and length of stay.

Main Results:

• Identified 560 weighted cases of JA in 2017.
• JA was more common in females (340) than males (220) and affected White children disproportionately (235 cases).
• Medicaid covered 61.6% of patients, with total hospital charges reaching $25,147,389 and a mean length of stay of 4.55 days.

Conclusions:

• Juvenile arthritis represents a considerable healthcare burden in the US pediatric population.
• Findings highlight disparities in prevalence and insurance coverage, particularly among Medicaid beneficiaries.
• Further research into targeted interventions and cost-effective management strategies for JA is warranted.